Clinical trial of adverse effect inhibition with glucosides of vitamin C and vitamin E in radiotherapy and chemotherapy.
Koizumi
Masahiko
M
Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Nishimura
Tsunehiko
T
Kagiya
Tsutomu
T
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D001932:Brain Neoplasms / Q000532:radiotherapy; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D016190:Carboplatin / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005960:Glucosides; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology / Q000517:prevention & control*; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology / Q000517:prevention & control*; D013125:Spinal Neoplasms / Q000532:radiotherapy / Q000556:secondary; D014810:Vitamin E / Q000008:administration & dosage* / Q000009:adverse effects
D005960:Glucosides; D014810:Vitamin E; D016190:Carboplatin; D017239:Paclitaxel; D001205:Ascorbic Acid